An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models.

Saved in:
Bibliographic Details
Title: An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models.
Authors: Moore CC (AUTHOR), Martin EN (AUTHOR), Lee GH (AUTHOR), Obrig T (AUTHOR), Linden J (AUTHOR), Scheld WM (AUTHOR), Moore, Christopher C1 (AUTHOR), Martin, Edward N (AUTHOR), Lee, Grace H (AUTHOR), Obrig, Tom (AUTHOR), Linden, Joel (AUTHOR), Scheld, W Michael (AUTHOR)
Source: BMC Infectious Diseases. 2008, Vol. 8 Issue 1, p141-141. 1p.
Database: Academic Search Ultimate
Description
ISSN:14712334
DOI:10.1186/1471-2334-8-141